Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is associated with disorders affecting the peripheral and the central nervous system. A high number of patients develop post-COVID-19 syndrome with the persistence of a large spectrum of symptoms, including neurological, beyond 4 wee...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in immunology Vol. 13; p. 1070379
Main Authors:	Bonetto, Valentina, Pasetto, Laura, Lisi, Ilaria, Carbonara, Marco, Zangari, Rosalia, Ferrari, Erica, Punzi, Veronica, Luotti, Silvia, Bottino, Nicola, Biagianti, Bruno, Moglia, Cristina, Fuda, Giuseppe, Gualtierotti, Roberta, Blasi, Francesco, Canetta, Ciro, Montano, Nicola, Tettamanti, Mauro, Camera, Giorgia, Grimoldi, Maria, Negro, Giulia, Rifino, Nicola, Calvo, Andrea, Brambilla, Paolo, Biroli, Francesco, Bandera, Alessandra, Nobili, Alessandro, Stocchetti, Nino, Sessa, Maria, Zanier, Elisa R.
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 15.12.2022
Subjects:	Amyotrophic Lateral Sclerosis Biomarkers blood biomarkers Blood-Brain Barrier COVID-19 COVID-19 - complications critical care Humans Immunology Inflammation Interleukin-10 Matrix Metalloproteinase 9 Nervous System Diseases - diagnosis neurological damages Pandemics Post-Acute COVID-19 Syndrome SARS-CoV-2 COVID-19 blood-brain barrier critical care blood biomarkers inflammation neurological damages
ISSN:	1664-3224, 1664-3224
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!